News | Latest Breaking News Stories & Headlines

The wave of lawsuits has crashed onto Bayer since its takeover of US seeds and pesticides maker Monsanto last year for $63 billion

Bayer facing 18,400 US cases over glyphosate

German pharmaceutical giant Bayer has said it is now targetted in some 18,400 US legal cases over glyphosate, a key herbicide ingredient that plaintiffs say caused grave illnesses like cancer.

Business • 30 Jul 19

Bayer paid $63 billion for Monsanto last year

US judge slashes Roundup jury award to $25.3m

A federal judge has cut a damages award Bayer owed a California man who blamed Roundup weed killer for his cancer, to $25.27m from $80.27m.

Business • 16 Jul 19

Bayer is seeking to address the fallout from US class-action litigation over glyphosate

Bayer to invest €5 billion in new weedkillers

Bayer, the German crop science and chemicals group reeling from US litigation over claims its glyphosate pesticide causes cancer, said it would invest €5 billion in weedkiller research.

Business • 14 Jun 19

Bayer said in a statement that it was disappointed with the Roundup verdict and would appeal

Bayer stock falls on $2 billion award in Roundup trial

Shares in Bayer were down 5.9% today after a jury awarded more than $2 billion to a California couple in the largest US jury verdict against the company over allegations its Roundup weedkiller causes cancer.

Business • 14 May 19

Bayer has seen about €30 billion wiped off its market value since August

Bayer gets Monsanto profit boost but legal burden grows

German drug and farming supplies company Bayer has today posted a 45% gain in quarterly core earnings thanks to the acquisition of seed maker Monsanto.

Business • 25 Apr 19

Hoping to ditch Monsanto's reputation, Bayer has said it plans to drop the name from its products

Five things to know about Bayer and Monsanto

The second cancer victim in a year to win a surprise victory against US pesticide maker Monsanto raises the prospect of a flood of similar lawsuits, potentially leaving the firm's new German owner Bayer with a major case of buyer's remorse.

Business • 20 Mar 19

A wave of lawsuits has put pressure on Bayer since its $63-billion takeover of Roundup maker Monsanto last year

Investors flee Bayer after second Roundup trial blow

The threat to German chemical giant Bayer and subsidiary Monsanto from US litigation swelled today, when its share price plunged after a jury ruled weedkiller Roundup was a "substantial factor" in a man's cancer.

Business • 20 Mar 19

Roundup Pro 360 is banned in France from today

France bans weed-killer after court ruling

French authorities have banned the sale of a form of controversial weed-killer Roundup following a court ruling that regulators failed to take safety concerns into account when clearing the widely used herbicide.

Europe • 15 Jan 19

In 2015, the cancer unit of the WHO classified glyphosate as 'probably carcinogenic to humans'

US judge upholds Monsanto verdict but slashes award

A US judge has upheld a jury verdict against Bayer subsidiary Monsanto in a historic case regarding the cancer danger of some of its weed killer products, but slashed the punitive damages award.

World • 23 Oct 18

Germany's Federal Institute for Drugs and Medical Devices has ordered the country's main drug industry associations to gather information on the effect of a no-deal Brexit

Germany advises drug makers to examine supply chain

German drug makers have been asked by the government to examine their supply chains for any vulnerability that could cause shortages of essential drugs in the event that Britain leaves the European Union without a Brexit deal.

Business • 29 Aug 18

Bayer shares plunge 14% after Roundup cancer trial

Shares in Bayer have plunged more than 14% to their lowest in almost five years - wiping around $14 billion off the value of the company - after a California jury ordered the German company's subsidiary Monsanto to pay $289m in damages last week.

Business • 13 Aug 18

Russia's competition regulator has approved Bayer's planned takeover of Monsanto

Russian nod moves Bayer closer to Monsanto deal

Russia's competition regulator FAS has approved Bayer's planned takeover of Monsanto, the German drugs and crop chemicals maker said, as it enters the home stretch to closing the $62.5 billion deal.

Business • 20 Apr 18

The Bayer-Monsanto deal would create a company with a share of over a quarter of the world's seed and pesticides market

Bayer reaches deal with US for approval to buy Monsanto

The US Justice Department will allow German drugs and pesticides group Bayer to acquire Monsanto in a $62.5 billion deal, according to US media reports.

Business • 10 Apr 18

The Bayer-Monsanto deal is set to create a company with control of more than a quarter of the world's seed and pesticides market

Bayer wins EU approval for $62.5 billion Monsanto buy

German conglomerate Bayer has today won EU competition approval for its $62.5 billion buy of US peer Monsanto, the latest in a trio of mega mergers that will reshape the agrochemicals industry.

Business • 21 Mar 18

The proposed deal has triggered protests from environmental and farming groups worried about their market power

Bayer to win EU approval for $62 billion Monsanto deal

German drug and crop chemicals maker Bayer is set to win conditional European Union competition approval for its $62.5 billion bid for the world's biggest seed company Monsanto.

Business • 28 Feb 18

BASF is the world's third-largest maker of crop chemicals

BASF to buy seeds, herbicide businesses from Bayer

BASF has agreed to buy significant parts of Bayer's seed and herbicide businesses for €5.9 billion in cash, the two companies said today.

Business • 13 Oct 17

Monsanto reaffirms its ongoing earnings per share target and raised its gross profit outlook for its seeds and genomics unit

Monsanto profit tops expectations on soybean sales

Seeds and agrochemicals company Monsanto, which is being bought by Germany's Bayer, reported a stronger-than-expected quarterly profit as record US and Brazilian soybean plantings lifted seed sales.

Business • 28 Jun 17

Monsanto is in the process of being bought by Germany's Bayer for $66 billion.

Monsanto posts better than expected jump in Q2 profit

US seeds and agrochemicals company Monsanto today reported a better than expected quarterly profit, helped by strong demand for its soybean and corn seeds.

Business • 05 Apr 17

Bayer wants to combine its crop chemicals business with Monsanto's industry leading seeds business

Bayer confirms $66 billion takeover of Monsanto

German drugs and crop chemicals company Bayer has confirmed that it has closed a deal to buy US seeds firm Monsanto for $66 billion.

Business • 14 Sep 16

Monsanto said Bayer's bid of $125 per share was 'financially inadequate' to ensure a deal

Monsanto calls Bayer's raised bid 'insufficient'

US agrochemical giant Monsanto said today that an increased takeover bid from Germany's Bayer was still "insufficient," but that it remains open to talks to seal the transaction.

Business • 19 Jul 16

Bayer sweetens its $64 billion bid for Monsanto

Bayer sweetens offer for hesitant Monsanto

German drug and crop chemical group Bayer has announced details of a sweetened $64 billion bid for Monsanto as it tries to put the US seed company under pressure to engage further.

Business • 15 Jul 16

The deal between Bayer and Monsanto would create the world's biggest agricultural supplier

Bayer announces $62bn cash offer for Monsanto

German drugs and crop chemicals group Bayer has offered to buy US seeds company Monsanto for $62bn in cash, including debt.

Business • 23 May 16

German group Bayer confirms talks to acquire US agriculture group Monsanto

German pharma giant Bayer in talks to buy Monsanto

German drugs and chemicals group Bayer has made an unsolicited takeover proposal to US seeds company Monsanto.

Business • 19 May 16

Germany's Bayer in deal to buy Merck's over-the-counter business

Bayer to buy Merck's OTC business for $14 billion

German chemicals and pharmaceuticals giant Bayer is to acquire the consumer care business of Merck Co in the US for $14.2 billion.

Business • 06 May 14

China has been investigating the practices of a number of international drug companies

China probing German drugmaker Bayer

Chinese authorities visited a local office of German drugmaker Bayer AG in late August to investigate a potential case of unfair competition, the company has said.

Business • 13 Sep 13

Bayer